Depresión/tratamiento farmacológico; Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos; Anciano; Humanos

Antidepressants; CGI; CI; CYP219; Clinical Global Impression (scale); Cytochrome P450 2C19; EPSE; FDA; HAM-D; Hamilton Depression Rating scale; MADRS; MHRA; Major depressive disorder; Medicines and Healthcare products Regulatory Agency; Montgomery-Åsberg Depression Rating scale; NNT; OR; PPIs; QT interval corrected (for heart rate); QTc; RCT; RR; Randomized controlled trials; Risks; SNRI (s); SSRI(s); Side effects; Suicide; TCA(s); US Food and Drug Administration; confidence interval; extrapyramidal side effects; numbers needed to treat; odds ratio; proton pump inhibitors; randomized controlled trial; risk ratio; serotonin reuptake inhibitor(s); serotonin­norepinephrine reuptake inhibitor(s); tricyclic antidepressants(s)